日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Overexpression of CTLA-4 and fibronectin, and lower expression of CD137 (4-1BB) is associated with brain metastasis of primary skin melanomas. An analysis of local immune response by digital spatial profiling

CTLA-4 和纤连蛋白的过表达以及 CD137 (4-1BB) 的低表达与原发性皮肤黑色素瘤的脑转移相关。通过数字空间分析法分析局部免疫反应。

Najjary, Shiva; Amery, Nur Al; Huang, Mengqi; Vadgama, Disha; van Akkooi, Alexander C J; Gilhuis, H Jacobus; Belcaid, Zineb; Mustafa, Dana; Kros, Johan M

NIMG-41. MULTI-SITE, PROSPECTIVE TRIAL EVALUATING FET-PET IN GLIOBLASTOMA (FIG) STUDY (TROG 18.06): PRELIMINARY RESULTS OF CENTRAL NUCLEAR MEDICINE REVIEW OF FET-PET BIOLOGIC TARGET VOLUME DELINEATION FOR RADIATION PLANNING

NIMG-41. 多中心前瞻性试验评估 FET-PET 在胶质母细胞瘤中的应用(FIG)研究(TROG 18.06):中心核医学审查 FET-PET 生物学靶区勾画用于放射治疗计划的初步结果

Singal, Amit G; Narasimman, Manasa; Daher, Darine; Yekkaluri, Sruthi; Liu, Yan; Lee, MinJae; Cerda, Vanessa; Khan, Aisha; Seif El Dahan, Karim; Kramer, Jennifer; Gopal, Purva; Murphy, Caitlin; Hernaez, Ruben; Baumert, Brigitta G; Hegi, Monika E; Van den Bent, Martin; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khe; Brandes, Alba A; Sargos, Paul; Taphoorn, Martin; Vauleon, Elodie; Phillips, Claire; Kros, Johan M; Bady, Pierre; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline; Jacob, Julian; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Anja; Rossiter, John; Lentz, Marie-Ange; Balana, Carmen; Azevedo, Ana Luisa Silva; Clement, Paul M; Berghoff, Anna; Tzuk, Tzahala; Weller, Michael; Nordal, Robert; Rees, Jeremy; Lacombe, Denis; Mason, Warren P; Stupp, Roger; Sener, Ugur; Uhm, Joon; Haddad, Tufia; Pritchett, Joshua; Rauf, Asad; Ahluwalia, Manmeet; Dhawan, Andrew; Ma, Yanxia; Nguyen, Nhat; He, Wei; Singh, Sanjay; Fu, Rongjie; Zhang, Liang; Holmen, Sheri; Jones, Phil; Davies, Michael; Xu, Han; Ene, Chibawanye; Kim, Byeongsoo; Lee, Haksoo; Kim, Dahye; Park, Junhyeong; Park, Sujin; Kang, JiHoon; Youn, HyeSook; Youn, BuHyun; Odukoya, Lateef; Ghomsi, Nathalie; Kabare, Gloria; Kamson, David; Eckel-Passow, Jeanette; Jenkins, Robert; Kitange, Gaspar; Akinjo, Andrea; Badmos, Kabir; Bankole, Olufemi; Idowu, Olufemi; Karekazi, Claire; Darko, Kwadwo; Edrick, Elias; Ekhator, Chukwuyem; Katasi, Victoria; Lachance, Daniel; Brown, Desmond; Huse, Jason; Llewellyn, Henry; Magambo, Margreth; Magoha, Michael; Ngaiza, Advera; Nyalundja, Arsene; Higgins, Dominique; Okenwa, Minda; Osei-Tutu, Lawrence; Petershie, Bernard; Yevudza, Elorm; Anunobi, Charles; Tiamiyu, Liadi; Gankpe, Gbetoho; Heronima, Kashaigili; Shroeder, Kristin; Fonkem, Ekokobe; Teddy, Totimeh; Balogun, James; Cheserem, Beverly; Zerd, Francis; Koh, Eng-Siew; Francis, Roslyn; Lee, SzeTing; Lau, Eddie; Thomas, Elizabeth; Whitehead, Angela; Cook, Olivia; Dykyj, Rachael; Moore, Alisha; Rossi, Alana; Thomas, Paul; Pattison, David; Akhurst, Tim; Alipour, Ramin; Hsiao, Edward; Schembri, Geoffrey; Lin, Peter; Yap, June; Ly, Tam; Kirkwood, Ian; Vallat, Wilson; Krishna, Dayanethee Krishna; Khan, Shahroz Khan; Ngai, Stanley Ngai; Yu, Chris; Beuzeville, Scott; Yeow, Tow Chan; Barry, Nathaniel; Ebert, Martin; Gan, Hui; Moffat, Bradford; Fitt, Greg; Ng, Sweet Ping; Pinkham, Mark; Bailey, Dale; Scott, Andrew M

CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY

CTNI-14. 放射治疗与替莫唑胺治疗高危低级别胶质瘤的比较。EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) III期研究中期随访13年后的最终结果

Hijaz, Baraa A; Volpicelli-Daley, Laura A; Baumert, Brigitta G; Hegi, Monika E; Van den Bent, Martin; von Deimling, Andreas; Gorlia, Thierry; Hoang-Xuan, Khe; Brandes, Alba A; Sargos, Paul; Taphoorn, Martin; Vauleon, Elodie; Phillips, Claire; Kros, Johan M; Bady, Pierre; Wick, Wolfgang; Enting, Roelien; Reni, Michele; Thiessen, Brian; Dhermain, Frederic; Bromberg, Jacoline; Jacob, Julian; Reijneveld, Jaap C; Chinot, Olivier; Gijtenbeek, Anja; Rossiter, John; Lentz, Marie-Ange; Balana, Carmen; Azevedo, Ana Luisa Silva; Clement, Paul M; Berghoff, Anna; Tzuk, Tzahala; Weller, Michael; Nordal, Robert; Rees, Jeremy; Lacombe, Denis; Mason, Warren P; Stupp, Roger

T lymphocyte-derived IFN-γ facilitates breast cancer cells to pass the blood-brain barrier: An in vitro study corroborating translational data.

T 淋巴细胞衍生的 IFN-γ 促进乳腺癌细胞穿过血脑屏障:一项体外研究证实了转化数据

Pedrosa Rute M S M, Kros Johan M, Schrijver Benjamin, Berrevoets Cor, Marques Rute B, van Eijck Casper C H J, Debets Reno, Leenen PieterJ M, Dik Willem A, Mustafa DanaA M

Association of blood cell-based inflammatory markers with gut microbiota and cancer incidence in the Rotterdam study

鹿特丹研究中基于血液细胞的炎症标志物与肠道菌群和癌症发病率的关联

Najjary, Shiva; Kros, Johan M; Stricker, Bruno H; Ruiter, Rikje; Shuai, Yu; Kraaij, Robert; Van Steen, Kristel; van der Spek, Peter; Van Eijck, Casper H J; Ikram, M Arfan; Ahmad, Shahzad

IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas

与 IDH1/2 野生型胶质母细胞瘤相比,具有胶质母细胞瘤样分子特征的 2 级和 3 级 IDH1/2 野生型胶质瘤的癫痫病程有所不同。

van Opijnen, Mark P; Tesileanu, C Mircea S; Dirven, Linda; van der Meer, Pim B; Wijnenga, Maarten M J; Vincent, Arnaud J P E; Broekman, Marike L D; Dubbink, Hendrikus J; Kros, Johan M; van Duinen, Sjoerd G; Smits, Marion; French, Pim J; van den Bent, Martin J; Taphoorn, Martin J B; Koekkoek, Johan A F

Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033

有丝分裂计数是 IDH 突变型星形细胞瘤(无 CDKN2A/B 纯合缺失)的预后指标。EORTC 26053 试验 (CATNON) 和 EORTC 22033-26033 试验的共识小组审查结果。

Kros, Johan M; Rushing, Elisabeth; Uwimana, Aimé L; Hernández-Laín, Aurelio; Michotte, Alex; Al-Hussaini, Maysa; Bielle, Franck; Mawrin, Christian; Marucci, Gianluca; Tesileanu, C Mircea S; Stupp, Roger; Baumert, Brigitta; van den Bent, Martin; French, Pim J; Gorlia, Thierry

Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042

DNA甲基化类别和1p染色体缺失对接受辅助高剂量放射治疗的WHO 2级和3级脑膜瘤的独立预后影响:EORTC 22042-26042的综合分子分析

Maas, Sybren L N; Sievers, Philipp; Weber, Damien C; Weller, Michael; van den Bent, Martin J; Mair, Maximilian J; Kros, Johan M; Carparrotti, Fransesca; von Deimling, Andreas; Salvador, Villà Freixa; Peerdeman, Saskia Marguerite; Casas-Martin, Jose; Gorlia, Thierry; Sahm, Felix; Preusser, Matthias

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers

体外药物敏感性筛选可预测胶质母细胞瘤患者对替莫唑胺的反应,并识别候选生物标志物。

Ntafoulis, Ioannis; Kleijn, Anne; Ju, Jie; Jimenez-Cowell, Kevin; Fabro, Federica; Klein, Michelle; Chi Yen, Romain Tching; Balvers, Rutger K; Li, Yunlei; Stubbs, Andrew P; Kers, Trisha V; Kros, Johan M; Lawler, Sean E; Beerepoot, Laurens V; Kremer, Andreas; Idbaih, Ahmed; Verreault, Maite; Byrne, Annette T; O'Farrell, Alice C; Connor, Kate; Biswas, Archita; Salvucci, Manuela; Prehn, Jochen H M; Lambrechts, Diether; Dilcan, Gonca; Lodi, Francesca; Arijs, Ingrid; van den Bent, Martin J; Dirven, Clemens M F; Leenstra, Sieger; Lamfers, Martine L M

Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers

揭示乳腺癌和肺癌配对脑转移的分子机制并识别可药物靶点

Najjary, Shiva; de Koning, Willem; Kros, Johan M; Mustafa, Dana A M